Guochun Cao

658 total citations
19 papers, 148 citations indexed

About

Guochun Cao is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Guochun Cao has authored 19 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Guochun Cao's work include Cancer Immunotherapy and Biomarkers (5 papers), Esophageal Cancer Research and Treatment (5 papers) and MicroRNA in disease regulation (3 papers). Guochun Cao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Esophageal Cancer Research and Treatment (5 papers) and MicroRNA in disease regulation (3 papers). Guochun Cao collaborates with scholars based in China, India and Canada. Guochun Cao's co-authors include Yayi Hou, Datong Zheng, Hui Wang, Qingling Wang, Yaling Huang, Jifeng Feng, Aiyun Li, Minggang Lei, Ya-Qin Wen and Ying Zhu and has published in prestigious journals such as Journal of Clinical Oncology, Osteoporosis International and Cellular Signalling.

In The Last Decade

Guochun Cao

15 papers receiving 143 citations

Peers

Guochun Cao
Jessica MacLean Canada
Ailith Ewing United Kingdom
Joyce Wei Ting Goh United Kingdom
Xiao Zeng China
Xianghua Ma China
Wenying Zheng China
Takashige Tobita Japan
Jessica MacLean Canada
Guochun Cao
Citations per year, relative to Guochun Cao Guochun Cao (= 1×) peers Jessica MacLean

Countries citing papers authored by Guochun Cao

Since Specialization
Citations

This map shows the geographic impact of Guochun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guochun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guochun Cao more than expected).

Fields of papers citing papers by Guochun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guochun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guochun Cao. The network helps show where Guochun Cao may publish in the future.

Co-authorship network of co-authors of Guochun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Guochun Cao. A scholar is included among the top collaborators of Guochun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guochun Cao. Guochun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Xu, Zhen, Zelin Wang, Chen Peng, et al.. (2025). PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression. Gut Microbes. 17(1). 2455508–2455508. 4 indexed citations
3.
Wang, Min, Wenhui Zhao, Ting Qian, et al.. (2024). CircATXN7 regulates the proliferation and invasion of esophageal cancer cells through miR-4319/NLRC5. Cellular Signalling. 122. 111341–111341.
4.
Qian, Ting, Delin Liu, Guochun Cao, Zhipeng Chen, & Qin Zhang. (2024). Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment. 23. 2233973498–2233973498. 1 indexed citations
5.
6.
Liu, Delin, et al.. (2022). Expression of CircATXN7 in esophageal cancer tissues and its effect on cell proliferation and invasion. Journal of Gastrointestinal Oncology. 13(3). 912–922. 1 indexed citations
7.
Jiang, Ming, Binhui Ren, Jingyuan Zhang, et al.. (2022). SCALE-1: Safety and efficacy of short course neoadjuvant chemo-radiotherapy plus toripalimab for locally advanced resectable squamous cell carcinoma of esophagus.. Journal of Clinical Oncology. 40(16_suppl). 4063–4063. 14 indexed citations
8.
Hou, Xiang, et al.. (2021). Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China. Osteoporosis International. 33(1). 89–96. 13 indexed citations
9.
Qian, Ting, Hui Zhang, Shaorong Yu, et al.. (2021). Knockdown of lncRNA TUC338 inhibits esophageal cancer cells migration and invasion. Journal of Thoracic Disease. 13(5). 3061–3069. 3 indexed citations
10.
Liu, Delin, Qin Zhang, Ting Qian, et al.. (2021). Phase-II study of toripalimab combined with neoadjuvant chemotherapy for the treatment of resectable esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 39(15_suppl). e16029–e16029. 6 indexed citations
11.
Peng, Wei, et al.. (2020). Clinical value of piR-36026 and piR-651 in esophageal squamous cell carcinoma.. Journal of Clinical Oncology. 38(15_suppl). e15265–e15265. 1 indexed citations
12.
Zhang, Sha, Peitao Xie, Haibin Shen, et al.. (2018). STAT3/c-Myc Axis-Mediated Metabolism Alternations of Inflammation-Related Glycolysis Involve with Colorectal Carcinogenesis. Rejuvenation Research. 22(2). 138–145. 20 indexed citations
13.
Chen, Ming, et al.. (2016). Partial response to chemotherapy in a patient with retroperitoneal inflammatory myofibroblastic tumor. Molecular and Clinical Oncology. 5(4). 463–466. 8 indexed citations
14.
Zheng, Datong, Yanping Chen, Yongyue Wei, et al.. (2014). Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer. Cancer Biology & Therapy. 15(11). 1542–1551. 14 indexed citations
15.
Song, Guohong, Xi Zhang, Ying Cheng, et al.. (2011). Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patients. Chinese Journal of Cancer Research. 23(4). 317–322. 6 indexed citations
16.
Cao, Guochun, et al.. (2008). Lung Cancer Risk Associated with Thr495Pro Polymorphism of GHR in Chinese Population. Japanese Journal of Clinical Oncology. 38(4). 308–316. 19 indexed citations
17.
Shi, Meiqi, Bo Shen, Guochun Cao, et al.. (2008). Comparison of efficacy and toxicity between gemcitabine plus cisplatin and plus carboplatin in first-line treatment of advanced non-small cell lung cancer. The Chinese-German Journal of Clinical Oncology. 7(4). 196–199.
18.
Huang, Yaling, Guochun Cao, Hui Wang, Qingling Wang, & Yayi Hou. (2007). The expression and location of midkine in gastric carcinomas of Chinese patients.. PubMed. 4(2). 135–40. 20 indexed citations
19.
Xiong, Yuanzhu, Rong Zheng, Aiyun Li, et al.. (2002). [Polymorphism of porcine myostatin gene].. PubMed. 29(4). 326–31. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jessica MacLean Breakdown of academic impact, for papers by Ailith Ewing Breakdown of academic impact, for papers by Joyce Wei Ting Goh Breakdown of academic impact, for papers by Xiao Zeng Breakdown of academic impact, for papers by Xianghua Ma Breakdown of academic impact, for papers by Wenying Zheng Breakdown of academic impact, for papers by Takashige Tobita
Rankless by CCL
2026